To include your compound in the COVID-19 Resource Center, submit it here.

NeoRecormon epoetin beta: Post-marketing study data

Data from the 3-year, open-label, international CREATE study in 603 patients with anemia related to chronic kidney

Read the full 174 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE